Bupropion Hydrochloride
Product Images NDC 55648-102

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bupropion Hydrochloride (NDC 55648-102). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Wockhardt Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Buprohclertabxl M Figure 01)

FDA Label Image

Label (Buprohclertabxl M Figure 02)

Label (Buprohclertabxl M Figure 02)
Each extended-release tablet contains 150 mg of bupropion hydrochloride, to be taken once daily as directed by a physician. The medication guide is provided separately for extended-release Reipmen Tablets, USP (XL). It is important to note that this medication should not be used in combination with ZYBAN or any other medication containing bupropion hydrochloride. Store at a controlled room temperature between 20°-25°C (68°-77°F). Information on dosage can be found in the packaging. This product is manufactured by a company located in Parsippany, NJ and comes in a package of 90 tablets. LOT and EXP information are not available in the text provided.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.